Cut the Chat Life Science Insider
Episodes
The Myth of Vendor Fit: How to Read RFPs Beyond the Polish
15 Dec 2025
Contributed by Lukas
A practical conversation on how biotechs can read RFPs differently, avoid the fluency trap, challenge assumptions, and choose vendors that can actuall...
Beyond the Checklist: The Hidden Risks in Clinical Systems Compliance
12 Nov 2025
Contributed by Lukas
Clinical systems compliance sounds like a box to tick, until the box breaks your trial.In this episode, Seuss+ CEO Kieran Engels and Lauren Alani, Dir...
Quality as Culture: Why Biotechs Can’t Afford to Get It Wrong
18 Sep 2025
Contributed by Lukas
Quality isn’t just a checkbox — it’s a biotech differentiator.What does “quality” really mean in biotech? And why does it so often get treat...
Innovation, Execution, and Equity in RNA-Based Women’s Health
15 Aug 2025
Contributed by Lukas
In this episode, Seuss+ CEO and Co-Founder Sabine Hutchison sits down with Klaas Zuideveld, CEO of Versameb, to discuss the scientific, clinical, and ...
Inside the Bid: What Sponsors Need to Know About CRO Pricing, Pressure & Proposals
17 Jul 2025
Contributed by Lukas
A look inside the proposal engine room - and how sponsors can rethink pricing, pressure, and partnership.Why do so many biotech sponsors feel blindsid...
Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development
19 Jun 2025
Contributed by Lukas
In this episode of The Life Science Insider, Kieran Canisius speaks with Limor Ben Har, COO of Prilenia Therapeutics, about what it takes to lead thro...
Two Questions, Zero Prep: What We’d Ask Each Other (If We Were the Guests)
22 Apr 2025
Contributed by Lukas
The Life Science Insider is back with a brand-new video-first format — and this kickoff episode gets real fast.In this raw, unscripted premiere, Seu...
AI in Biotech: Hype, Reality, and the Future of Drug Development
16 Oct 2024
Contributed by Lukas
In this episode, Christina Busmalis and Sabine dive deep into the evolving intersection of AI and drug development. They explore the challenges and op...
Transforming Clinical Trials: How Digital Endpoints Are Leading the Way
04 Sep 2024
Contributed by Lukas
We explore the transformative potential of digital endpoints in clinical trials, emphasizing their role in revolutionizing data collection for patient...
Navigating the Commercialization Journey: Insights from Science to Market
07 May 2024
Contributed by Lukas
In the second episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the dynamic Kirsten Detrick, whose extensive experie...
Bridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions
03 Apr 2024
Contributed by Lukas
Sabine Hutchison talks to the inspiring investor Stephanie Oestreich.In the first episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founde...
Mastering the Art of Collaboration: Principal Investigator and Biotech Dynamics
29 Nov 2023
Contributed by Lukas
Sabine Hutchison sits down with the incredible Viviënne van de Walle a highly respected principal investigator who brings her wealth of experience to...
Cross-Pollination and DEI Strategies with Ben Osborn
25 Oct 2023
Contributed by Lukas
In Episode 4 of "Cut the Chat," host Sabine Hutchison engages in a thought-provoking discussion with Ben Osborn, a prominent figure in the biopharma i...
Cracking the code: Navigating the Ever-Changing Biotech Landscape
13 Sep 2023
Contributed by Lukas
Join Seuss+ CEO and Co-Founder Sabine Hutchison as she sits down with the accomplished Dr. Allison Jeynes-Ellis, a visionary leader whose journey span...
Innovation Unleashed: Exploring the Intersection of Science and Creativity – An Unconventional Growth Strategy
09 Aug 2023
Contributed by Lukas
Seuss+ CEO and Co-Founder Sabine Hutchison delves into the remarkable growth strategy and remarkable journey of Agenus Bio, a standout player in the c...
Smart KPIs for Biotechs
29 Jun 2023
Contributed by Lukas
Seuss+ CEO and Co-Founder Sabine Hutchison is joined by Alan Morgan. Alan has worked as a leader in the industry for 25 years and sits down with Sabin...